Evaluation of bioequivalence after oral, intramuscular, and intravenous administration of racemic ketoprofen in pigs

Marja R. Raekallio Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, PO Box 57, University of Helsinki, Fl-00014 Helsinki, Finland.

Search for other papers by Marja R. Raekallio in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Katja M. Mustonen Vetcare Ltd, PO Box 99, FI-24101 Salo, Finland.

Search for other papers by Katja M. Mustonen in
Current site
Google Scholar
PubMed
Close
 DVM
,
Mari L. Heinonen Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, FI-04920 Saarentaus, Finland.

Search for other papers by Mari L. Heinonen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Olli A. T. Peltoniemi Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, FI-04920 Saarentaus, Finland.

Search for other papers by Olli A. T. Peltoniemi in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Mia S. Säkkinen Division of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Helsinki, FI-04920 Saarentaus, Finland.

Search for other papers by Mia S. Säkkinen in
Current site
Google Scholar
PubMed
Close
 PhD
,
S. Marikki Peltoniemi Division of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Helsinki, FI-04920 Saarentaus, Finland.

Search for other papers by S. Marikki Peltoniemi in
Current site
Google Scholar
PubMed
Close
 PhD
,
Juhana M. Honkavaara Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, PO Box 57, University of Helsinki, Fl-00014 Helsinki, Finland.

Search for other papers by Juhana M. Honkavaara in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Outi M. Vainio Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, PO Box 57, University of Helsinki, Fl-00014 Helsinki, Finland.

Search for other papers by Outi M. Vainio in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Click on author name to view affiliation information

Abstract

Objective—To assess bioequivalence after oral, IM, and IV administration of racemic ketoprofen in pigs and to investigate the bioavailability after oral and IM administration.

Animals—8 crossbred pigs.

Procedures—Each pig received 4 treatments in a randomized crossover design, with a 6-day washout period. Ketoprofen was administered at 3 and 6 mg/kg, PO; 3 mg/kg, IM; and 3 mg/kg, IV. Plasma ketoprofen concentrations were measured by use of high-performance liquid chromatography for up to 48 hours. To assess bioequivalence, a 90% confidence interval was calculated for the area under the time-concentration curve (AUC) and maximum plasma concentration (Cmax).

Results—Equivalence was not detected in the AUCs among the various routes of administration nor in Cmax between oral and IM administration of 3 mg/kg. The bioavailability of ketoprofen was almost complete after each oral or IM administration. Mean ± SD Cmax was 5.09 ± 1.41 μg/mL and 7.62 ± 1.22 μg/mL after oral and IM doses of 3 mg/kg, respectively. Mean elimination half-life varied from 3.52 ± 0.90 hours after oral administration of 3 mg/kg to 2.66 ± 0.50 hours after IV administration. Time to peak Cmax after administration of all treatments was approximately 1 hour. Increases in AUC and Cmax were proportional when the orally administered dose was increased from 3 to 6 mg/kg.

Conclusions and Clinical Relevance—Orally administered ketoprofen was absorbed well in pigs, although bioequivalence with IM administration of ketoprofen was not detected. Orally administered ketoprofen may have potential for use in treating pigs.

Abstract

Objective—To assess bioequivalence after oral, IM, and IV administration of racemic ketoprofen in pigs and to investigate the bioavailability after oral and IM administration.

Animals—8 crossbred pigs.

Procedures—Each pig received 4 treatments in a randomized crossover design, with a 6-day washout period. Ketoprofen was administered at 3 and 6 mg/kg, PO; 3 mg/kg, IM; and 3 mg/kg, IV. Plasma ketoprofen concentrations were measured by use of high-performance liquid chromatography for up to 48 hours. To assess bioequivalence, a 90% confidence interval was calculated for the area under the time-concentration curve (AUC) and maximum plasma concentration (Cmax).

Results—Equivalence was not detected in the AUCs among the various routes of administration nor in Cmax between oral and IM administration of 3 mg/kg. The bioavailability of ketoprofen was almost complete after each oral or IM administration. Mean ± SD Cmax was 5.09 ± 1.41 μg/mL and 7.62 ± 1.22 μg/mL after oral and IM doses of 3 mg/kg, respectively. Mean elimination half-life varied from 3.52 ± 0.90 hours after oral administration of 3 mg/kg to 2.66 ± 0.50 hours after IV administration. Time to peak Cmax after administration of all treatments was approximately 1 hour. Increases in AUC and Cmax were proportional when the orally administered dose was increased from 3 to 6 mg/kg.

Conclusions and Clinical Relevance—Orally administered ketoprofen was absorbed well in pigs, although bioequivalence with IM administration of ketoprofen was not detected. Orally administered ketoprofen may have potential for use in treating pigs.

All Time Past Year Past 30 Days
Abstract Views 115 0 0
Full Text Views 798 591 51
PDF Downloads 248 99 12
Advertisement